Search Results
Exploring the Rationale, Results, and Real-World Clinical Potential of BTKi in the Management of MS
Potential of BTK inhibitors in MS
BTK Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
MS and BTK Inhibitors
Updates on RADIUS-R & RADIUS-P: elezanumab for patients with relapsing and progressive forms of MS
BTK inhibitors for multiple sclerosis: progressive disease and de-escalation
Using Real World Evidence to Weight Efficacy of Treatment
BTK inhibitors: Investigating disease relevant mechanisms in multiple sclerosis
Targeting BTK in the Treatment of Patients With MS
Fernando Dangond, AAN 2019 – Phase II study of first oral BTK inhibitor in multiple sclerosis
Multiple Sclerosis Vlog: Answering Viewers Questions
MS Researcher Anne Cross Makes Significant Contributions to Multiple Sclerosis Research & Treatments